Skip to content
CancerIndex

Loading the knowledge graph…

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM — knowledge graph · CancerIndex